MetLife Investment Management’s Axogen AXGN Stock Holding History

MetLife Investment Management’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$881K	Buy	26,581 +924	+4%	+$30K	﹤0.01%	1459
2025 Q4	$840K	Hold	25,657	–	–	﹤0.01%	1527
2025 Q3	$458K	Hold	25,657	–	–	﹤0.01%	1850
2025 Q2	$278K	Hold	25,657	–	–	﹤0.01%	2001
2025 Q1	$475K	Sell	25,657 -377	-1%	-$6.8K	﹤0.01%	1755
2024 Q4	$429K	Buy	26,034 +2,319	+10%	+$32.8K	﹤0.01%	1886
2024 Q3	$332K	Hold	23,715	–	–	﹤0.01%	2001
2024 Q2	$172K	Buy	23,715 +5,939	+33%	+$40.6K	﹤0.01%	2343
2024 Q1	$143K	Sell	17,776 -5,288	-23%	-$47.4K	﹤0.01%	2367
2023 Q4	$158K	Hold	23,064	–	–	﹤0.01%	2372
2023 Q3	$115K	Hold	23,064	–	–	﹤0.01%	2509
2023 Q2	$211K	Hold	23,064	–	–	﹤0.01%	2243
2023 Q1	$218K	Hold	23,064	–	–	﹤0.01%	2160
2022 Q4	$230K	Hold	23,064	–	–	﹤0.01%	2158
2022 Q3	$275K	Hold	23,064	–	–	﹤0.01%	2085
2022 Q2	$189K	Hold	23,064	–	–	﹤0.01%	2365
2022 Q1	$183K	Buy	23,064 +8,224	+55%	+$71K	﹤0.01%	2400
2021 Q4	$139K	Buy	14,840 +4,519	+44%	+$54.2K	﹤0.01%	2278
2021 Q3	$163K	Sell	10,321 -5,155	-33%	-$92.6K	﹤0.01%	2208
2021 Q2	$334K	Hold	15,476	–	–	﹤0.01%	1819
2021 Q1	$314K	Hold	15,476	–	–	﹤0.01%	1789
2020 Q4	$277K	Hold	15,476	–	–	﹤0.01%	1808
2020 Q3	$180K	Hold	15,476	–	–	﹤0.01%	1920
2020 Q2	$143K	Hold	15,476	–	–	﹤0.01%	2077
2020 Q1	$161K	Hold	15,476	–	–	﹤0.01%	1810
2019 Q4	$277K	Hold	15,476	–	–	﹤0.01%	1805
2019 Q3	$193K	Hold	15,476	–	–	﹤0.01%	1970
2019 Q2	$306K	Hold	15,476	–	–	﹤0.01%	1771
2019 Q1	$326K	Hold	15,476	–	–	﹤0.01%	1714
2018 Q4	$316K	Hold	15,476	–	–	﹤0.01%	1644
2018 Q3	$570K	Hold	15,476	–	–	0.01%	1451
2018 Q2	$778K	Buy	15,476 +1,758	+13%	+$77.5K	0.01%	1141
2018 Q1	$501K	Hold	13,718	–	–	0.01%	1363
2017 Q4	$388K	Buy	+13,718	New	+$324K	﹤0.01%	1552

Other funds holding AXGN

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's AXGN Position: Q1 2026 in Review

MetLife Investment Management increased its Axogen (AXGN) stake by 3.6% in Q1 2026, buying an estimated $30K and bringing the position to 26,581 shares worth $881K. The position accounts for ﹤0.01% of the portfolio, ranked #1459.

MetLife Investment Management first reported a position in AXGN in Q4 2017 and has held it in 34 quarters since. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

MetLife Investment Management held 26,581 shares of Axogen worth $881K as of Q1 2026.
MetLife Investment Management bought 924 Axogen shares in Q1 2026, an estimated $30K.
Axogen made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1459 holding.
MetLife Investment Management first reported a position in Axogen in Q4 2017 and has held it in 34 quarters since.
220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.